about
Future of adenoviruses in the gene therapy of arthritisProgress in cancer gene therapy.Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins.Current status of viral gene therapy for brain tumours.LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesGene therapy for superficial bladder cancer.Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.Gene transfer in tissue repair: status, challenges and future directions.Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cellsSynaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis miceOverexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus.Hyperthermia and gene therapy: potential use of microPET imaging.Gene therapy and wound healingAdenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses.Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.Characterization of a recombinant adenovirus vector encoding heat-inducible feline interleukin-12 for use in hyperthermia-induced gene-therapy.v-Ha-ras mitogenic signaling through superoxide and derived reactive oxygen species.RNA interference with special reference to combating viruses of crustacea.Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming.Molecular biology and neurosurgery in the third millennium.In-vivo particle mediated delivery of mRNA to mammalian tissues: ballistic and biologic effects.
P2860
Q24805400-0A0A2F10-DA95-4E7A-86C9-0D4E076962DAQ33752288-A9F2C879-9B5F-487A-A4C3-97E91374DA2DQ33782516-158C701B-53A7-4D70-8E0A-F5FCB60B0DF8Q33785925-C7BDA79D-3C26-4EC7-81C8-C03520C00D69Q34074791-BDBBC0C1-80F2-403A-816D-47C1D912FE47Q34467839-74919B43-3850-4EA9-B94D-C883F099F5AAQ34734147-3C524536-3127-4B8F-91A7-B4115C1544B7Q35057135-5E280801-087A-48E6-9D4E-8C14782E2E37Q35873744-F27CE090-3DF0-41B1-9C70-80AAB7BA3CD6Q35895708-36E486A7-3B9D-425C-A1A1-27880B1E9ACFQ35962446-117FC682-5276-4B2B-954C-BB4BF8BB63C7Q36316660-62F58A7F-DDF2-4A21-9B2E-FBDACDC4CE32Q36401348-87F18CFC-3973-4597-A99D-0907FDF6DABCQ36497619-D0254FB6-5D18-4460-AB25-5B8B3C484FBFQ36727410-B0DD034A-21AA-427F-856D-52E5EC8DBEA1Q37378133-5E0E1151-A91E-48FB-9AB6-0DEC668AB76BQ39882372-5F490DC8-DC0D-44FB-B78F-A943458A913BQ40271356-8614B968-C8EA-4773-B957-E10F94E05E0CQ40740270-DDFD9CF1-45A1-4FD0-8714-43C9BE029394Q42272671-716AA946-FBE1-4024-9A39-6DB5409A1753Q45862071-58069C61-EAB3-4D46-8A6B-D647DEA2DA72Q45867483-4E47617F-EFCB-491B-B890-4ECEAEA03254Q45881095-7DAF61D4-8106-4C7E-8EEC-83B175FB47A2
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Second-generation adenovirus vectors.
@en
type
label
Second-generation adenovirus vectors.
@en
prefLabel
Second-generation adenovirus vectors.
@en
P2860
P356
P1433
P1476
Second-generation adenovirus vectors.
@en
P2860
P2888
P304
P356
10.1038/NM0696-714
P407
P577
1996-06-01T00:00:00Z